These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 8419069

  • 21. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.
    Hagen EC, Daha MR, Hermans J, Andrassy K, Csernok E, Gaskin G, Lesavre P, Lüdemann J, Rasmussen N, Sinico RA, Wiik A, van der Woude FJ.
    Kidney Int; 1998 Mar; 53(3):743-53. PubMed ID: 9507222
    [Abstract] [Full Text] [Related]

  • 22. T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG).
    Brouwer E, Stegeman CA, Huitema MG, Limburg PC, Kallenberg CG.
    Clin Exp Immunol; 1994 Dec; 98(3):448-53. PubMed ID: 7994909
    [Abstract] [Full Text] [Related]

  • 23. Anti-neutrophil cytoplasm antibodies (ANCA).
    Savige JA, Davies DJ.
    Aust N Z J Med; 1990 Jun; 20(3):271-4. PubMed ID: 2196872
    [Abstract] [Full Text] [Related]

  • 24. Antineutrophil cytoplasmic autoantibodies: immunobiological aspects.
    Gross WL, Csernok E, Schmitt WH.
    Klin Wochenschr; 1991 Sep 03; 69(13):558-66. PubMed ID: 1721666
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Antineutrophil cytoplasmic autoantibody-associated diseases: a rheumatologist's perspective.
    Gross WL, Schmitt WH, Csernok E.
    Am J Kidney Dis; 1991 Aug 03; 18(2):175-9. PubMed ID: 1867175
    [Abstract] [Full Text] [Related]

  • 29. [Antineutrophil cytoplasmic antibodies].
    Sebastiani GD.
    Reumatismo; 2009 Aug 03; 61(1):69-76. PubMed ID: 19370191
    [Abstract] [Full Text] [Related]

  • 30. [Wegener's granulomatosis and ANCA-associated vasculitis: pathogenic role of autoantigens, autoantibodies, and cytokines].
    Kekow J, Csernok E, Szymkowiak CH, Gross WL.
    Immun Infekt; 1993 Apr 03; 21 Suppl 1():44-8. PubMed ID: 8344692
    [Abstract] [Full Text] [Related]

  • 31. Clinical and pathological manifestations of patients with antineutrophil cytoplasmic autoantibodies directed against proteinase 3 or myeloperoxidase.
    Zhang X, Dong Y, Zeng X, Li Y, Tang F.
    Chin Med Sci J; 2002 Mar 03; 17(1):32-5. PubMed ID: 12894882
    [Abstract] [Full Text] [Related]

  • 32. 'Classic' anti-neutrophil cytoplasmic autoantibodies (cANCA), 'Wegener's autoantigen' and their immunopathogenic role in Wegener's granulomatosis.
    Gross WL, Csernok E, Flesch BK.
    J Autoimmun; 1993 Apr 03; 6(2):171-84. PubMed ID: 8388690
    [Abstract] [Full Text] [Related]

  • 33. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives.
    Radice A, Vecchi M, Bianchi MB, Sinico RA.
    Clin Exp Rheumatol; 2000 Apr 03; 18(6):707-12. PubMed ID: 11138332
    [Abstract] [Full Text] [Related]

  • 34. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
    Schirmer JH, Wright MN, Herrmann K, Laudien M, Nölle B, Reinhold-Keller E, Bremer JP, Moosig F, Holle JU.
    Arthritis Rheumatol; 2016 Dec 03; 68(12):2953-2963. PubMed ID: 27333332
    [Abstract] [Full Text] [Related]

  • 35. Comparison of eight commercial kits for quantitation of antineutrophil cytoplasmic antibodies (ANCA).
    Wang G, Csernok E, de Groot K, Gross WL.
    J Immunol Methods; 1997 Oct 27; 208(2):203-11. PubMed ID: 9433475
    [Abstract] [Full Text] [Related]

  • 36. Membrane surface proteinase 3 expression and intracytoplasmic immunoglobulin on neutrophils from patients with ANCA-associated vasculitides.
    Csernok E, Schmitt WH, Ernst M, Bainton DF, Gross WL.
    Adv Exp Med Biol; 1993 Oct 27; 336():45-50. PubMed ID: 8296655
    [Abstract] [Full Text] [Related]

  • 37. Pathogenesis of PR3-ANCA associated vasculitis.
    Kallenberg CG.
    J Autoimmun; 2008 Oct 27; 30(1-2):29-36. PubMed ID: 18162369
    [Abstract] [Full Text] [Related]

  • 38. Antineutrophil cytoplasmic antibodies (ANCA): diagnostic utility and potential role in the pathogenesis of vasculitis.
    Malenica B, Rudolf M, Kozmar A.
    Acta Dermatovenerol Croat; 2004 Oct 27; 12(4):294-313. PubMed ID: 15588565
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of proteinase 3 by ANCA and its correlation with disease activity in Wegener's granulomatosis.
    Daouk GH, Palsson R, Arnaout MA.
    Kidney Int; 1995 Jun 27; 47(6):1528-36. PubMed ID: 7643521
    [Abstract] [Full Text] [Related]

  • 40. Advances in pathogenesis and treatment of ANCA-associated vasculitis.
    Kallenberg CG.
    Discov Med; 2014 Oct 27; 18(99):195-201. PubMed ID: 25336033
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.